Skip to main content
Tim Fischell, MD, Cardiology, Kalamazoo, MI

TimAlexanderFischellMDFACC, MSCAI, FNAI

Cardiology Kalamazoo, MI

Interventional Cardiology

Professor, Medicine, Michigan State University, College of Human Medicine

Dr. Fischell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fischell's full profile

Already have an account?

  • Office

    1722 Shaffer St
    Suite 1
    Kalamazoo, MI 49048
    Phone+1 269-381-3963
    Fax+1 269-381-2809

Summary

  • I am an academic cardiologist. I’ve had a keen interest in complex coronary disease, and I am a dedicated CTO operator. Also, medical device entrepreneur. Started ~ 10 companies in areas of coronary stenting. renal denervation (Ablative Solutions, Founder), Ostial Solutions, AngelMed/implantable heart attack detector (now Avertix), Vantis/CrossLiner next generation guide extension, etc.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Interventional Cardiology, 1986 - 1987
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Cardiology, 1984 - 1987
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Internal Medicine, 1981 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1981 - 1984
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1981 - 1982
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1981
  • Cornell University
    Cornell UniversityA.B, Neurobiology/Psychology, Distinction, 1974 - 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2027
  • MI State Medical License
    MI State Medical License 1996 - 2027
  • AZ State Medical License
    AZ State Medical License 2015 - 2026
  • TX State Medical License
    TX State Medical License 2019 - 2025
  • FL State Medical License
    FL State Medical License 2012 - 2020
  • TN State Medical License
    TN State Medical License 1992 - 1998
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology
  • National Board of Physicians and Surgeons Cardiovascular Disease
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Interventional Cardiology

Awards, Honors, & Recognition

  • Who’s Who Among Processionals in Research 2006
  • Who’s Who Metropolitan Professional Honor Society 2006
  • Fellow (FACP) American College of Physicians, 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Radioactive Stents: The American View. 
    Second International Thoraxcenter Course on Intracoronary Stenting. Rotterdam, Netherlands
  • The Radioisotope Stent: An Update. 
    Advanced Cardiovascular Guidance: Utilizing New Technologies for Treatment of Vascular Disease, Atla
  • Rationale for Primary Stenting of De-novo Coronary Artery Lesions. 
    Michigan Chapter, American College of Cardiology Meetings, Traverse City, Michigan
  • Join now to see all

Press Mentions

  • Society for Cardiovascular Angiography and Interventions Bestows Highest Designation Ranking to Leading Interventional Cardiologists
    Society for Cardiovascular Angiography and Interventions Bestows Highest Designation Ranking to Leading Interventional CardiologistsMay 10th, 2022
  • Ablative Solutions, Inc., Was Founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD,
    Ablative Solutions, Inc., Was Founded in 2011 by Tim Fischell, MD, FACC, and David Fischell, PhD,June 26th, 2019
  • Ablative Solutions, Inc. Announces $77 Million Financing for Unique Therapeutic Approach to Treating Uncontrolled Hypertension
    Ablative Solutions, Inc. Announces $77 Million Financing for Unique Therapeutic Approach to Treating Uncontrolled HypertensionJanuary 3rd, 2019
  • Join now to see all

Grant Support

  • Human Arterial Vasoreactivity Following InjuryNational Heart, Lung, And Blood Institute1987–1991
  • Human Coronary Artery Vasoreactivity Following InjuryNational Heart, Lung, And Blood Institute1986–1987

Professional Memberships